Connection

Miguel Abboud to Patient Dropouts

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Patient Dropouts.
Miguel Abboud
Connection Strength
0.025
Patient Dropouts
  1. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.